Catalyst Pharmaceuticals, Inc. et al v. Lupin Ltd. et al
| Catalyst Pharmaceuticals, Inc. and SERB SA |
| Lupin Ltd., Lupin Inc. and Lupin Pharmaceuticals, Inc. |
| 1:2023cv00229 |
| March 2, 2023 |
| US District Court for the District of Delaware |
| Maryellen Noreika |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on May 5, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 9 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: #1 Notice of Voluntary Dismissal)(mdb) |
| Filing 8 NOTICE of Voluntary Dismissal by Catalyst Pharmaceuticals, Inc., SERB SA as to all Defendants (Viceconte, Christopher) |
| CASE CLOSED (dlw) |
| CORRECTING ENTRY: D.I. 7 has been deleted from the docket and re-filed using the proper event code: ANDA Form found under civil, other documents. (dlw) |
| Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) |
| Filing 7 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: Catalyst - 1/27/2023; SERB - 1/30/2023. Date of Expiration of Patents: Various. Thirty Month Stay Deadline: 7/30/2025. (dlw) |
| Filing 6 Summons Issued as to Lupin Inc., Lupin Ltd., and Lupin Pharmaceuticals, Inc. on 3/2/2023. (Attachments: #1 Summons Issued Lupin Ldt., #2 Summons Issued Lupin Pharmaceuticals, Inc.)(jfm) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by SERB SA. (jfm) |
| Filing 4 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Catalyst Pharmaceuticals, Inc. (jfm) |
| Filing 3 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 10,626,088; US 10,793,893; US 11,060,128; US 11,268,128; US 11,274,331; US 11,274,332. (jfm) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) |
| Filing 1 COMPLAINT for PATENT INFRINGEMENT filed against Lupin Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc. (Filing fee $ 402, receipt number ADEDC-4080170.) - filed by Catalyst Pharmaceuticals, Inc., SERB SA. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Civil Cover Sheet)(jfm) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
